Cargando…
Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience
BACKGROUND: It is generally believed that patients with Hürthle cell thyroid carcinoma (HCTC) have a poor prognosis. Furthermore, distant metastases represent the most frequent cause of thyroid cancer-related death of patients with HCTC. The aim of this study was to report the treatment and outcomes...
Autores principales: | Besic, Nikola, Schwarzbartl-Pevec, Andreja, Vidergar-Kralj, Barbara, Crnic, Tea, Gazic, Barbara, Marolt Music, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768323/ https://www.ncbi.nlm.nih.gov/pubmed/26921186 http://dx.doi.org/10.1186/s12885-016-2179-3 |
Ejemplares similares
-
Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
por: Zagar, Ivana, et al.
Publicado: (2012) -
Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
por: Petric, Rok, et al.
Publicado: (2016) -
Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms
por: Vogrin, Andrej, et al.
Publicado: (2016) -
Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
por: Besic, Nikola, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience
por: Besic, Nikola, et al.
Publicado: (2015)